Concord Biotech Financials
NSE: CONCORDBIO | BSE: 543960
₹1,443.20
₹26.10
(1.84%)
As on 07-Sep-2026IST
Market cap
₹15,091 Cr
Revenue (TTM)
₹1,108 Cr
P/E Ratio
54.8
P/B Ratio
7.3
Div. Yield
0.5 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
1,108.39
|
1,054.89
|
1,200.09
|
1,016.94
|
853.17
|
712.93
|
|
|
|
|
|
|
Total Income
|
1,159.90
|
1,107.25
|
1,244.53
|
1,050.72
|
888.48
|
736.35
|
|
|
|
|
|
|
Total Expenditure
|
720.01
|
686.95
|
693.24
|
584.75
|
504.59
|
439.01
|
|
|
|
|
|
|
EBITDA
|
388.38
|
367.94
|
506.84
|
432.19
|
348.58
|
273.93
|
|
|
|
|
|
|
Depreciation
|
74.78
|
74.46
|
54.37
|
53.59
|
54.03
|
50.05
|
|
|
|
|
|
|
EBIT
|
313.60
|
293.48
|
452.47
|
378.60
|
294.55
|
223.88
|
|
|
|
|
|
|
Interest
|
0.26
|
0.82
|
1.04
|
3.18
|
9.80
|
6.14
|
|
|
|
|
|
|
Other Income
|
51.50
|
52.36
|
44.45
|
33.78
|
35.31
|
23.42
|
|
|
|
|
|
|
Exceptional Items
|
-3.28
|
-3.28
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
361.56
|
344.65
|
494.55
|
412.57
|
322.01
|
237.52
|
|
|
|
|
|
|
Provision for Tax
|
91.39
|
85.42
|
122.91
|
104.46
|
81.93
|
62.59
|
|
|
|
|
|
|
Profit after Tax
|
270.18
|
259.23
|
371.64
|
308.10
|
240.09
|
174.93
|
|
|
|
|
|
|
Minority Interest
|
2.51
|
1.68
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
2.69
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
275.37
|
260.91
|
371.64
|
308.10
|
240.09
|
174.93
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,017.06
|
2,017.06
|
1,812.72
|
1,526.65
|
1,290.00
|
1,103.22
|
|
|
|
|
|
|
Minority Interest
|
2.51
|
-1.92
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
50.51
|
47.58
|
37.47
|
31.91
|
32.14
|
54.40
|
|
|
|
|
|
|
Current Liabilities
|
169.08
|
169.08
|
184.06
|
142.16
|
191.84
|
344.24
|
|
|
|
|
|
|
Total Liabilities
|
2,234.73
|
2,231.79
|
2,034.25
|
1,700.71
|
1,513.98
|
1,501.87
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
957.22
|
981.68
|
899.01
|
804.48
|
786.28
|
869.20
|
|
|
|
|
|
|
Current Assets
|
1,250.11
|
1,250.11
|
1,135.24
|
896.23
|
727.70
|
632.67
|
|
|
|
|
|
|
Total Assets
|
2,234.73
|
2,231.79
|
2,034.25
|
1,700.71
|
1,513.98
|
1,501.87
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
0.38
|
6.23
|
31.24
|
60.59
|
|
|
|
|
|
|
Net Current Assets
|
1,081.04
|
1,081.03
|
951.18
|
754.08
|
535.86
|
288.42
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
3.76
|
3.91
|
14.31
|
14.31
|
13.32
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
266.88
|
244.52
|
265.47
|
246.00
|
207.48
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-142.72
|
-159.99
|
-154.61
|
-157.95
|
-111.79
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-112.88
|
-98.77
|
-99.21
|
-85.22
|
-100.16
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
11.28
|
-14.24
|
11.64
|
2.83
|
-4.48
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
26.55
|
24.94
|
35.52
|
29.45
|
22.95
|
16.72
|
|
|
|
|
|
|
Cash EPS (₹)
|
26.32
|
31.90
|
40.72
|
34.57
|
28.11
|
21.50
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
198.20
|
192.81
|
173.27
|
145.93
|
123.31
|
105.45
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.52
|
7.55
|
10.70
|
8.75
|
6.83
|
5.12
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
25.51
|
23.37
|
25.38
|
23.51
|
218.14
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
21.47
|
13.77
|
18.62
|
9.25
|
49.86
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
18.04
|
29.62
|
29.13
|
26.70
|
21.66
|
|
|
|
|
|
|
ROE (%)
|
14.45
|
13.54
|
22.26
|
21.88
|
20.06
|
16.64
|
|
|
|
|
|
|
ROA (%)
|
12.66
|
12.15
|
19.90
|
19.17
|
15.92
|
12.43
|
|
|
|
|
|
|
EBIT Margin (%)
|
28.29
|
27.82
|
37.70
|
37.23
|
34.52
|
31.40
|
|
|
|
|
|
|
Net Margin (%)
|
23.29
|
23.41
|
29.86
|
29.32
|
27.02
|
23.76
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
31.63
|
35.50
|
35.57
|
34.47
|
30.99
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-6.72
|
-12.10
|
18.01
|
19.20
|
19.67
|
15.56
|
|
|
|
|
|
|
EBIT Growth (%)
|
-26.64
|
-35.14
|
19.51
|
28.54
|
31.57
|
-25.48
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-21.99
|
-30.25
|
20.62
|
28.33
|
37.25
|
-25.53
|
|
|
|
|
|
|
EPS Growth (%)
|
-22.67
|
-29.80
|
20.62
|
28.33
|
37.25
|
-25.51
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
11.27
|
18.74
|
18.34
|
16.93
|
10.39
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
54.80
|
40.73
|
47.19
|
51.68
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
7.28
|
5.27
|
9.67
|
10.43
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.52
|
0.74
|
0.64
|
0.57
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
34.28
|
25.25
|
31.81
|
34.08
|
0.00
|
-0.06
|
|
|
|
|
|
|
Close Price (₹)
|
1,280.20
|
1,018.40
|
1,680.60
|
1,520.80
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
1,980.00
|
2,150.40
|
2,664.00
|
1,608.20
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
987.00
|
990.00
|
1,326.90
|
741.00
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
15,090.89
|
10,627.92
|
17,537.35
|
15,922.01
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
0.00
|
0.00
|
0.02
|
0.05
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
0.00
|
--
|
--
|
0.00
|
|
|
|
|
|
|
Current Ratio
|
7.39
|
7.39
|
6.17
|
6.30
|
3.79
|
1.84
|
|
|
|
|
|
|
Quick Ratio
|
5.46
|
5.46
|
4.87
|
4.84
|
2.69
|
1.27
|
|
|
|
|
|
|
Interest Coverage
|
1,386.30
|
419.57
|
475.76
|
130.57
|
33.85
|
39.72
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
41.52
|
43.63
|
43.47
|
34.38
|
32.09
|
32.57
|
|
|
|
|
|
|
Asset Turnover
|
0.52
|
0.49
|
0.64
|
0.63
|
0.57
|
0.52
|
|
|
|
|
|
|
Receivable days
|
--
|
169.86
|
132.49
|
111.87
|
108.22
|
102.99
|
|
|
|
|
|
|
Inventory Days
|
--
|
97.92
|
68.07
|
75.42
|
87.15
|
87.67
|
|
|
|
|
|
|
Payable days
|
--
|
159.68
|
123.94
|
149.88
|
179.16
|
144.10
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
108.11
|
76.63
|
37.41
|
16.22
|
46.55
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
